Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.8983 per EA under NDC 43598064260. Its NADAC has been published 67 times since Mar 19, 2025.
Strength
75 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598064260
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208048On Market Since
2/28/2025
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 67 times since Mar 19, 2025, and over the history we have for it it has declined 49.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8983 per EA |
|---|---|
| All-time high | $1.7717 (Apr 16, 2025) |
| All-time low | $0.8478 (Apr 22, 2026) |
| 52-week high | $1.4699 |
| 52-week low | $0.8478 |
| Median price | $1.1059 |
| Average price | $1.2017 |
| Largest weekly change | -11.0% (Aug 20, 2025) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dabigatran etexilate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Dr. Reddy's Laboratories Inc., is $0.8983 per EA (NDC 43598064260), effective Jun 24, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 49.3%. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Mar 19, 2025, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8478 (Apr 22, 2026) to a high of $1.7717 (Apr 16, 2025), with a median of $1.1059 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DABIGATRAN ETEXILATE 75 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 43598064260) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification